INDUS PHARMACEUTICALS - Trademark Details
Status: 800 - Registered And Renewed
Image for trademark with serial number 78596173
Serial Number
78596173
Registration Number
3674488
Word Mark
INDUS PHARMACEUTICALS
Status
800 - Registered And Renewed
Status Date
2019-10-03
Filing Date
2005-03-28
Registration Number
3674488
Registration Date
2009-08-25
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2006-03-21
Attorney Name
Law Office Assigned Location Code
L80
Employee Name
BHANOT, KAPIL KUMAR
Statements
Disclaimer with Predetermined Text
"PHARMACEUTICALS"
Goods and Services
pharmaceutical drug development services of pharmaceutical products intended for the treatment of infectious diseases, namely, bacterial, fungal, parasitic and viral infections; pharmaceutical drug development services of pharmaceutical products intended for the treatment of neoplastic disorders, namely, hematologic cancer disorders and solid tumors; pharmaceutical drug development services of pharmaceutical products intended for the treatment of autoimmune disorders, namely, diabetes, arthritis, psoriasis, bone marrow and organ transplantation and immunosuppression; pharmaceutical drug development services of pharmaceutical products intended for the treatment of metabolic disorders, namely, obesity and atherosclerosis; pharmaceutical drug development services of pharmaceutical products intended for the treatment of cardiovascular disorders, namely, hypertension, congestive heart failure, myocardial infarction, angina and vascular diseases; pharmaceutical drug development services of pharmaceutical products intended for the treatment of renal disorders, namely, acute and chronic renal failure and urinary disorders affecting renal conservation of water; pharmaceutical drug development services of pharmaceutical products intended for the treatment of central nervous system disorders, namely, analgesia, anesthesia, hypnotics, sedatives, anxiety, psychosis, depression, mania, epilepsies, migraine, neurodegeneration, and drug addiction; pharmaceutical drug development services of pharmaceutical products intended for the treatment of inflammatory disorders, namely, asthma, gout, inflammatory bowel disease, and rheumatoid arthritis; pharmaceutical drug development services of pharmaceutical products intended for the treatment of gastrointestinal disorders, namely, ulcers, emesis, diarrhea, and irritable bowel syndrome; pharmaceutical drug development services of pharmaceutical products intended for the treatment of hormonal disorders affecting the thyroid, estrogens, progestins, androgens, glucocorticoids, insulin and glucose regulation; pharmaceutical drug development services of pharmaceutical products intended for the treatment of calcification and bone turnover; and pharmaceutical drug development services of pharmaceutical products intended for the treatment of dermatological and opthalmological disorders
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2005-04-01
Primary Code
042
First Use Anywhere Date
2006-03-31
First Use In Commerce Date
2006-03-31
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
H. Straat Tenney
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2005-04-01NEW APPLICATION ENTERED IN TRAM
2005-10-22ASSIGNED TO EXAMINER
2005-10-25EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
2005-10-25EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
2005-11-17TEAS RESPONSE TO OFFICE ACTION RECEIVED
2005-11-17CORRESPONDENCE RECEIVED IN LAW OFFICE
2005-11-23TEAS/EMAIL CORRESPONDENCE ENTERED
2005-11-29EXAMINERS AMENDMENT -WRITTEN
2005-11-29EXAMINERS AMENDMENT E-MAILED
2005-11-29APPROVED FOR PUB - PRINCIPAL REGISTER
2005-12-02ASSIGNED TO LIE
2006-02-03LAW OFFICE PUBLICATION REVIEW COMPLETED
2006-03-01NOTICE OF PUBLICATION
2006-03-21PUBLISHED FOR OPPOSITION
2006-06-13NOA MAILED - SOU REQUIRED FROM APPLICANT
2006-12-13TEAS EXTENSION RECEIVED
2006-12-13EXTENSION 1 FILED
2006-12-13EXTENSION 1 GRANTED
2007-06-13TEAS EXTENSION RECEIVED
2007-06-13EXTENSION 2 FILED
2007-06-13EXTENSION 2 GRANTED
2007-12-13TEAS EXTENSION RECEIVED
2007-12-13EXTENSION 3 FILED
2007-12-13EXTENSION 3 GRANTED
2008-01-08ASSIGNED TO EXAMINER
2008-06-12TEAS EXTENSION RECEIVED
2008-06-12EXTENSION 4 FILED
2008-06-12EXTENSION 4 GRANTED
2008-12-10TEAS EXTENSION RECEIVED
2008-12-10EXTENSION 5 FILED
2008-12-10EXTENSION 5 GRANTED
2009-06-15TEAS STATEMENT OF USE RECEIVED
2009-07-09CASE ASSIGNED TO INTENT TO USE PARALEGAL
2009-06-13USE AMENDMENT FILED
2009-07-09STATEMENT OF USE PROCESSING COMPLETE
2009-07-13ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2009-07-21ASSIGNED TO LIE
2009-07-21LAW OFFICE REGISTRATION REVIEW COMPLETED
2009-08-25REGISTERED-PRINCIPAL REGISTER
2015-08-21TEAS SECTION 8 & 15 RECEIVED
2015-09-25CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2015-09-25REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
2015-09-25NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
2016-01-22TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-08-25COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
2019-08-23TEAS SECTION 8 & 9 RECEIVED
2019-10-03CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2019-10-03REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
2019-10-03REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
2019-10-03NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED